Read here about the Food and Drug Administration’s (FDA) updates for Hepatitis B Virus (HBV)

Here is the latest highlight on Human Immunodeficiency Virus (HIV) and its impact to the Human Tissue industry

Here is our latest blog the FDA Guidance document: “Recommendations to Reduce the Risk of Transmission of Disease Agents with Sepsis by Human Cells, Tissues, and Cellular and Tissue Based Products (HCT/Ps)

Delayed implementation of 5/4/25

Here is our newest blog on the FDA guidance document:

“Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)”.

Background information on the implementation delay from the FDA with regard to Sepsis and Mtb.

A quick overview of the most recent FDA Guidance Documents for HCT/Ps!

Here is how your organization can adjust to the recent AATB 24-1 Bulletin